The change in plasma GABA, glutamine and glutamate levels in fluoxetine- Or S-citalopram-treated female patients with major depression

European Journal of Clinical Pharmacology

Volumn 65, Issue 6, 2009, Pages 571-577

  Küçükibrahimoğlu, Esra ^a   Saygın, Melek Z ^b   Çalışkan, Mecit ^b   Kaplan, Okan K ^b   Ünsal, Cüneyt ^b   Gören, M Zafer ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Turkish Ministry of Health   (Turkey)

Author keywords

Antidepressant therapy; Biomarker; SSRI; Therapy control

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; GLUTAMIC ACID; GLUTAMINE;

ARTICLE; BLOOD; CASE CONTROL STUDY; DEPRESSION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; DEPRESSION; FEMALE; FLUOXETINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; HUMANS;

EID: 68849108132     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-009-0650-7     Document Type: Article

References (45)

1. Klerman GL, Weissman MM (1988) The changing epidemiology of depression. Clin Chem 34:807-812
2. Angst J, Preisig M (1995) Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from (1959) to 1985. Arch Neuro Psychiatr 146:5-16
3. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522
4. Slattery DA, Hudson AL, Nutt DJ (2004) Invited review: The evolution of antidepressant mechanisms. Fundam Clin Pharmacol 18:1-21 (Pubitemid 38200913)
5. 3 H]GABA in nerve terminals of rat cerebral cortex by electromicroscopic autoradiography. Nature 229:628-630
6. B receptors in mammalian brain: potential targets for drug development. Drug Dev Res 21:161-167
7. Zhou FM, Hablitz JJ (1999) Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 82:2989-2999
8. Feng J, Cai X, Zhao J, Yan Z (2001) Serotonin receptors modulate GABAA receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J Neurosci 21:6502-6511 (Pubitemid 32781094)
9. Cai X, Flores-Hernandez J, Feng J, Yan Z (2002) Activity-dependent bi-directional regulation of GABAA receptor channels by serotonin 5-HT4 receptors in pyramidal neurons of the prefrontal cortex. J Physiol 540:743-759 (Pubitemid 35190149)
10. Yan Z (2002) Regulation of GABAA receptor channels by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications. Mol Neurobiol 26:203-216
11. Brambilla P, Perez J, Barale F, Shettini G, Soares JC (2003) GABAergic dysfunction in mood disorders. Mol Psychiatry 8:721-737 (Pubitemid 36976430)
12. Fiske E, Gronli J, Bjorvatn B, Ursin R, Portas CM (2006) The effect of GABA(A) antagonist bicuculline on dorsal raphe nucleus and frontal cortex extracellular seroton: a window on SWS and REM sleep modulation. Pharmacol Biochem Behav 83:314 - 321
13. Serrats J, Artigas F, Mengod G, Cortes R (2003) GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. J Neurochem 4:743-752 (Pubitemid 36176933)
14. Tao R, Ma Z, Auerbach SB (1996) Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats. Br J Pharmacol 119:1375-1384 (Pubitemid 26402015)
15. Petty F (1995) GABA and mood disorders: a brief review and hypothesis. J Affect Disord 34:275 -281
16. Freund TF (1992) GABAergic septal and serotonergic median raphe afferents preferentially innervate inhibitory interneurons in the hippocampus and dentate gyrus. Epilepsy Res 7:79-91
17. Freund TF, Gulyas AI, Acsady L, Gorcs T, Toth K (1990) Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci USA 87:8501-8505
18. Halasky K, Miettinen R, Szabat E, Freund TF (1992) GABAergic interneurons are the major postsynaptic targets of median raphe afferents in the rat dentate gyrus. Eur J Neurosci 4:144- 153
19. Gören MZ, Kucukibrahimoglu E, Berkman K, Terzioglu B (2007) Fluoxetine Partly Exerts Its Actions Through GABA: A Neurochemical Evidence. Neurochem Res 32(9):1559- 1565
20. Rowley HL, Martin KF, Marsden CA (1995) Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phythalaldehyde-sulphite derivatisation. J Neurosci Methods 57:93-99
21. Smith S, Sharp T (1994) Measurement of GABA in rat brain microdialysates using o-phthaldialdehyde-sulphite derivatization and high-performance liquid chromatography with electrochemical detection. J Chromatogr B 652:228-233 (Pubitemid 24081330)
22. Löscher W, Frey H-H (1982) Transport of GABA at the Blood-CSF Interface. J Neurochem 38(4):1072-1079 (Pubitemid 12113159)
23. Vignolo L, Cupello A, Mainardi P, Rapallino MV, Patrone A, Loeb C (1992) Accumulation of labeled gamma-aminobutyric acid into rat brain and brain synaptosomes after i.p. injection. Neurochem Res 17(2):193-199
24. Petty F, Kramer GL, Gullian CM, Rush AJ (1992) Low plasma GABA levels in male patients with depression. Biol Psychiatry 32:354-363
25. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159:663-665
26. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB (2003) Increased cortical GABA concentrations in depressed patients receiving ETC. Am J Psychiatry 160:577-579 (Pubitemid 41094271)
27. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M (1992) Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex 2:503-512
28. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
29. Sanacora G, Guegorguieva R (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 7:705-713 (Pubitemid 38890805)
30. Kendell SF, Krystal JH, Sanacora G (2005) GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets 9:153-168 (Pubitemid 40331202)
31. Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 11:1310-1316 (Pubitemid 350060893)
32. Novak G, Trullas R, Layer RT, Skolnick P, Paul IA (1993) Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther 65:1380-1386 (Pubitemid 23321045)
33. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P (1994) Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 69:95-102 (Pubitemid 24143240)
34. Nonaka S, Hough CJ, Chuang DM (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl- D -aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 95:2642-2647 (Pubitemid 28145996)
35. Popik P, Wrobel M, Nowak G (2000) Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Neuropharmacology 39:2278-2287 (Pubitemid 30642770)
36. Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185:1-10 (Pubitemid 20254891)
37. Layer RT, Popik P, Olds T, Skolnick P (1995) Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacol Biochem Behav 52:621-627
38. Przegalinski E, Tatarczynska E, Chojnacka-Wojcik E (2000) The influence of the benzodiyazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats. Neuropharmacology 39:1858-1864 (Pubitemid 30398489)
39. Berman RB, Cappiello A, Anand A (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 4:351-354 (Pubitemid 30109248)
40. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864
41. Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR, Kawahara R (2006) Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Progr Neuro-Psychopharmacol Biol Psychiatry 6:1155-1158 (Pubitemid 43928219)
42. Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ, Pettegrew JW (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 7:586-593 (Pubitemid 30169251)
43. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000) Reduced glutamate in the anterior cingulate cortex in depression: An in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47:305-313 (Pubitemid 30109243)
44. Pfleiderer B, Nikolaus M, Andreas E, Ohrmann P, Hohmann U, Wolgasta M, Fiebich M, Arolt V, Heindel W (2003) Effective electroconvulsive therapy reverses glutamateyglutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res Neuroimaging 122:185-192 (Pubitemid 36412193)
45. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B (2003) Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med 33:1277-1284